Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | SCD | O00767 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 2/20 | 0.30 |
| ▸ | ACACA | Q13085 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2298336 | 0.84 | ESR1 (0.36) | MAPK14MAPK1NPSR1ALOX5SCD | |
| SCHEMBL2231441 | 0.84 | PDE10A (0.37) | PPARGALOX5AP | |
| SCHEMBL13582005 | 0.82 | CYP4F2 (0.36) | ALOX5PPARGPKM | |
| SCHEMBL13582003 | 0.82 | CYP4F2 (0.36) | ALOX5PPARGPKM | |
| SCHEMBL2232840 | 0.80 | MAPT (0.35) | — | |
| SCHEMBL2298327 | 0.78 | CA12 (0.38) | — | |
| SCHEMBL2231791 | 0.67 | PPARG (0.40) | ALOX5PPARGACACBACACA | |
| SCHEMBL2235842 | 0.67 | TDP1 (0.37) | MAPK1ALOX5PPARG | |
| SCHEMBL2231445 | 0.67 | HTR2A (0.36) | ALOX5PPARGALOX5AP | |
| SCHEMBL2233200 | 0.67 | ALOX5 (0.35) | ALOX5PPARGALOX5APACACBACACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011093524-A1 | DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2011-08-04 | — | — | WO | disclosed |